Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells
Open Access
- 1 June 2013
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 13 (1) , 54
Abstract
Background: Apigenin (4’,5,7-trihydroxyflavone) was recently shown effective in inhibiting several cancers. The aim of this study was to investigate the effect and mechanism of apigenin in the human bladder cancer cell line T24 for the first time. Methods: T24 cells were treated with varying concentrations and time of apigenin. Cell viability was evaluated by MTT assay. Cell motility and invasiveness were assayed by Matrigel migration and invasion assay. Flow cytometry and western blot analysis were used to detect cell apoptosis, cell cycle and signaling pathway. Results: The results demonstrated that apigenin suppressed proliferation and inhibited the migration and invasion potential of T24 bladder cancer cells in a dose- and time-dependent manner, which was associated with induced G2/M Phase cell cycle arrest and apoptosis. The mechanism of action is like to involve PI3K/Akt pathway and Bcl-2 family proteins. Apigenin increased caspase-3 activity and PARP cleavage, indicating that apigenin induced apoptosis in a caspase-dependent way. Conclusions: These findings suggest that apigenin may be an effective way for treating human bladder cancer.Keywords
This publication has 35 references indexed in Scilit:
- Apigenin induces apoptosis and impairs head and neck carcinomas EGFR/ErbB2 signalingFrontiers in Bioscience-Landmark, 2011
- Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivoCancer Science, 2010
- Akt-induced promotion of cell-cycle progression at G2/M phase involves upregulation of NF-Y binding activity in PC12 cellsJournal of Cellular Physiology, 2005
- Farnesyltransferase Inhibitors Induce DNA Damage via Reactive Oxygen Species in Human Cancer CellsCancer Research, 2005
- Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by AktOncogene, 2004
- PI3K/Akt and apoptosis: size mattersOncogene, 2003
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002
- Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death MachineryCell, 1997
- Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria BlockedScience, 1997
- Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancerCancer Immunology, Immunotherapy, 1992